Advertisement
Canada markets open in 3 hours 11 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7325
    +0.0001 (+0.02%)
     

  • CRUDE OIL

    83.92
    +0.35 (+0.42%)
     

  • Bitcoin CAD

    87,960.26
    +855.62 (+0.98%)
     

  • CMC Crypto 200

    1,391.67
    -4.86 (-0.35%)
     

  • GOLD FUTURES

    2,361.00
    +18.50 (+0.79%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,732.75
    +165.25 (+0.94%)
     

  • VOLATILITY

    15.66
    +0.29 (+1.89%)
     

  • FTSE

    8,115.73
    +36.87 (+0.46%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     

Rakovina Therapeutics receives government grant to accelerate novel cancer therapy program

News Direct
·1 min read

Vancouver --News Direct-- Rakovina Therapeutics Inc

Rakovina Therapeutics chief scientific officer Mads Daugaard joined Proactive's Steve Darling to share news the company is receiving research and development funding from the National Research Council of Canada Industrial Research Assistance Program.

Daugaard tells Proactive the non-dilutive financing will provide its scientists in the development of DNA-damage response inhibitors with the goal of selecting one or more lead compounds for advancement to either toxicology and/or investigational new drug studies.

Contact Details

Proactive Investors

ADVERTISEMENT

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/rakovina-therapeutics-receives-government-grant-to-accelerate-novel-cancer-therapy-program-514861447